Expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 cancer-testis antigens in fetal testis

Acta Dermatovenerologica Croatica

Volumn 17, Issue 2, 2009, Pages 103-107

  Hudolin, Tvrtko ^a   Kaštelan, Željko ^a   Derežić, Danijel ^a   Bašić Jukić, Nikolina ^a   Spagnoli, Giulio Cesare ^b   Juretić, Antonio ^a   Ježek, Davor ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cancer antigens; Development; Fetal testes; MAGE A; NY ESO 1

Indexed keywords

CANCER TESTIS ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; NY ESO 1 ANTIGEN;

ARTICLE; CONTROLLED STUDY; FETUS; FETUS DEVELOPMENT; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; PREGNANCY; PROTEIN EXPRESSION; SEXUAL DEVELOPMENT; SPERMATOGONIUM; STAINING; TESTIS;

ANTIGENS, NEOPLASM; FEMALE; FETUS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PREGNANCY; PROSTATIC NEOPLASMS; TESTIS;

EID: 68149165372     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003;194:272-88.
2. Jungbluth AA, Silva WA Jr, Iversen K, Frosina D, Zaidi B, Coplan K, et al. Expression of cancer-testis (CT) antigens in placenta. Cancer Immun 2007;24:7-15.
3. Laduron S, Deplus R, Zhou S, Kholmanskikh O, Godelaine D, De Smet C, et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acid Res 2004;32:4340-50.
4. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, et al. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999;190:1669-78.
5. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
6. Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, et al. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 2001; 92:2778-2785.
7. Gjerstorff MF, Kock K, Nielsen O, Ditzel HJ. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development. Hum Reprod 2007;22:953-60.
8. Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, et al. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate 2006;66:13-8.
9. Pauls K, Schorle H, Jeske W, Brehm R, Steger K, Wernert N, et al. Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study. Hum Reprod 2006;21:397-404.
10. Satie AP, Rajpert-De Meyts E, Spagnoli GC, Henno S, Olivo L, et al. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest 2002;82:775-80.
11. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K,et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-60.